[SLRX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
23-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 74.41%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 1,840 5,233 3,465 838 1,275 1,011 -
PBT -31,608 -12,768 -7,352 -6,938 -21,922 -34,434 -39,493 -3.64%
Tax -233 -64 -256 -1,329 152 -325 -277 -2.84%
NP -31,375 -12,704 -7,097 -5,609 -21,922 -34,434 -39,493 -3.76%
Tax Rate - - - - - - - -
Total Cost 31,375 14,545 12,330 9,074 22,760 35,709 40,504 -4.16%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 -690.37 -135.61 -161.88 -2,615.99 -2,700.71 -3,906.33 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -14.77 -7.68 -11.39 -42.90 -760.47 -1,246.84 -1,520.48 -53.79%
EPS Diluted -14.77 -7.68 -11.39 -42.90 -760.47 -1,246.84 -1,520.48 -53.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.